AMBIT Trademark

Trademark Overview

On Monday, July 22, 2013, a trademark application was filed for AMBIT with the United States Patent and Trademark Office. The USPTO has given the AMBIT trademark a serial number of 86016594. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 28, 2015. This trademark is owned by Ambit Biosciences Corporation. The AMBIT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of oncological, autoimmune and inflammatory diseases and disorders
ambit

General Information

Serial Number86016594
Word MarkAMBIT
Filing DateMonday, July 22, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 28, 2015
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 1, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment and prevention of oncological, autoimmune and inflammatory diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 26, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAmbit Biosciences Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameAmbit Biosciences Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Monday, December 28, 2015ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, December 28, 2015ABANDONMENT - NO USE STATEMENT FILED
Thursday, June 4, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 3, 2015EXTENSION 2 GRANTED
Friday, May 15, 2015EXTENSION 2 FILED
Friday, May 15, 2015TEAS EXTENSION RECEIVED
Monday, December 1, 2014ASSIGNED TO EXAMINER
Friday, November 7, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 6, 2014EXTENSION 1 GRANTED
Thursday, October 16, 2014EXTENSION 1 FILED
Tuesday, November 4, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, October 16, 2014TEAS EXTENSION RECEIVED
Tuesday, May 27, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 1, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 1, 2014PUBLISHED FOR OPPOSITION
Wednesday, March 12, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, February 24, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, February 22, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 10, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 10, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 10, 2014ASSIGNED TO LIE
Monday, February 10, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 12, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 12, 2013NON-FINAL ACTION E-MAILED
Tuesday, November 12, 2013NON-FINAL ACTION WRITTEN
Monday, November 4, 2013ASSIGNED TO EXAMINER
Friday, July 26, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, July 25, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

ambit inflammatory diseases disorders autoimmune oncological preparations treatment prevention pharmaceutical